News & Media
Media
FEATURED
Defence Therapeutics announces 3 clinical trials for 2023
FEATURED
Defence Therapeutics spotlight on BTV
Developing Next Generation Biopharmaceutical Innovations
Making a Global Impact
News Releases
Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Million
Vancouver, BC, Canada, May 26th, 2023 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce that, in addition to...
Breakthrough Results: Defences Arm Vaccine Cured 100% of Animals with Pre-established Lymphoma
Vancouver, BC, Canada, May 24th 2023 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the successful...
Defence’s Successful Accutox™ Pre-Clinical Efficacy Study Complete Ready for Phase I and Filing
Vancouver, BC, Canada, May 2nd, 2023 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immuneoncology vaccines and drug delivery technologies is please to announce the successful completion...
USPTO Grants Trademark Registration for Defence Therapeutics®
Vancouver, BC, Canada, April 27, 2023 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that the United States Patent and...